ATHE

NASD Alterity Therapeutics Ltd Sponsored ADR
Oct 21, 2026 · 5:45 PM ET LAST TRADE Market Closed

$2.39 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.39, $0.23 below the day’s high of $2.62

YTD change
-22.40%
vs 20-day SMA
-24.80%
vs 200-day SMA
-40.64%

Price ranges

Previous day
$2.37 $2.51
open $2.41 close $2.37
-$0.04 (-1.66%)
Today
$2.30 $2.62
open $2.44 now $2.39
-$0.05 (-2.05%)
Past week
$2.35 $3.40
from $2.85 now $2.39
-$0.46 (-16.14%)
Past month
$2.35 $3.99
from $3.78 now $2.39
-$1.39 (-36.77%)
This year
$2.30 $5.89
from $3.08 now $2.39
-$0.69 (-22.40%)

Price & Performance

-2.49 (-51.18%) / 6M

$2.09$3.45$4.81$6.17Apr 21Jul 22Oct 20

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 95.4% away from all-time highs of $51.50
  • ATHE is down 22% since the beginning of the year
  • ATHE is down 50% over the past 12 months
  • ATHE is down 37% over the past 1 month
  • 0% of all ATHE investors are betting against ATHE

ATHE reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -50.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $15.9M
Beta -0.15

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$25.9M
Debt$134.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $43.3M

Alterity Therapeutics Ltd. engages in the business of research and development of therapeutic drugs designed to treat neurodegenerative diseases, focusing on Parkinsonian and other movement disorders. Its lead candidate, ATH434, is an oral small molecule drug designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,283.66 +3.49%
JNJ Johnson & Johnson $259.36 +2.19%
ABBV AbbVie, Inc. $289.08 +2.26%
MRK Merck & Co., Inc. $148.30 +3.25%
RHHVF Roche Holding Ltd $475.00 +3.69%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.